Demo
Close Language Tab
Locate us
Languages
V
Vimta Labs Ltd Healthcare
₹ 656.25 -54.05 (-7.61%)
  • NSE
  • BSE

Overview

  • BSE Code 524394
  • NSE Symbol VIMTALABS
  • ISIN Demat INE579C01029
  • Book Value (₹) 85.12
  • Face Value (₹) 2.00
  • Market Cap (₹ Cr.) 2,340.55
  • P/E (TTM) 32.93
  • EPS (TTM) 15.97
  • Div Yield (%) 0.19

Performance

Today’s Low 620.30
Today’s High 702.70

656.25
52W Low 242.05
52W High 721.50

656.25
Open 699.95
Prev. Close 710.30
Volume 2,56,86,238.00

Corporate Actions

Vimta Labs Limited - Outcome of Board Meeting
Apr 28, 2025

Vimta Labs Limited has informed the Exchange regarding Outcome of Board Meeting held on April 28, 2025.

Vimta Labs Limited - Outcome of Board Meeting
Apr 28, 2025

Vimta Labs Limited has informed the Exchange regarding Outcome of Board Meeting held on April 28, 2025.

Vimta Labs Limited - Investor Presentation
Apr 28, 2025

Vimta Labs Limited has informed the Exchange about Investor Presentation

Vimta Labs Limited - Investor Presentation
Apr 28, 2025

Vimta Labs Limited has informed the Exchange about Investor Presentation

Vimta Labs Limited - Dividend
Apr 28, 2025

Vimta Labs Limited has informed the Exchange that Board of Directors at its meeting held on April 28, 2025, recommended Final Dividend of 2 per equity share.

Vimta Labs Limited - Dividend
Apr 28, 2025

Vimta Labs Limited has informed the Exchange that Board of Directors at its meeting held on April 28, 2025, recommended Final Dividend of Rs. 2 per equity share.

Vimta Labs Limited - Outcome of Board Meeting
Apr 28, 2025

Vimta Labs Limited has informed the Exchange regarding Outcome of Board Meeting held on April 28, 2025. Appointment of Secretarial Auditor.

Vimta Labs Limited - Change in Director(s)
Apr 28, 2025

Vimta Labs Limited has informed the Exchange regarding Change in Director(s) of the company.

Vimta Labs Limited - Bonus
Apr 28, 2025

Vimta Labs Limited has informed the Exchange that the Board of Directors at its meeting held on April 28, 2025, have considered and approved bonus at the ratio of 1 : 1, i.e 1 Equity Shares for every 1 Equity Shares held.

Vimta Labs Limited - Press Release
Apr 28, 2025

Vimta Labs Limited has informed the Exchange regarding a press release dated April 28, 2025, titled "Vimta Labs Limited Reports Q4 & FY25 Results".

About Vimta Labs Ltd

Vimta Labs Ltd was Incorporated in the year 1990. The Laboratory was created and deployed in 1984 and successfully engineered a wide range of resources and testing capabilities. The Company is engaged in Contract Research and Analytical Testing Services. The Streams of Research and Testing are Contract Research (Clinical and Pre-clinical),Clinical Reference Laboratory Services (Central Lab), Analytical Testing of water,food,drugs etc.,and Environmental Monitoring and Impact Assessment.

The Company was awarded ISO 9002 Certification under ISO/IEC Guide-25 as Certified Competent Laboratory and Quality Endorsed Company by Standards Australia Quality Assurance Services Pty. Ltd in 1994.

In 1997, the Company broadened its footprint operations into into a Joint Venture with Russian Centre for Testing and Certification, ROSTEST Moscow with an investment of 24% of the total Paidup Captial. The main essence of this Joint Venture was to diversify the activities in to preshipment inspection services for all Indian exports to Russia.

During 2002, the company begun to offer Clinical Diagnostics Services. Clinical Specialty Diagnostics has been an internal requirement to screen the clinical trial subjects. Facilities were created in the year 2000 to speed up the clinical trials.

The Company is now expanding its operations by five times of its existing capacities at S P Biotech Park, Genome Valley, Turkapally Village, Shamirpet Mandal, Ranga Reddy Dist. The project is expected to commence from September 2005.

Founded: 1990
Chairman: S P Vasireddi
Managing Director: Harita Vasireddi
Address: Plot No 141/2 & 142, IDA Phase II Cherlapally, Hyderabad, Telangana, 500051,